▶ 調査レポート

人工心肺装置の世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Artificial Cardiopulmonary Machine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。人工心肺装置の世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Artificial Cardiopulmonary Machine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D0804-00781資料のイメージです。• レポートコード:D0804-00781
• 出版社/出版日:GlobalInfoResearch / 2020年7月21日
※2025年版があります。お問い合わせください。

• レポート形態:英語、PDF、108ページ
• 納品方法:Eメール
• 産業分類:医療機器・医療消耗品
• 販売価格(消費税別)
  Single User¥504,600 (USD3,480)▷ お問い合わせ
  Multi User¥756,900 (USD5,220)▷ お問い合わせ
  Corporate User¥1,009,200 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、人工心肺装置の世界市場を広く調査・分析し、今後の市場展望をまとめております。人工心肺装置の種類別市場規模(シングルローラーポンプHLM、ダブルローラーポンプHLM)、用途別市場規模(心臓外科、肺移植手術、急性呼吸不全治療、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):LivaNova (Sorin)、Terumo CV Group、Getinge (Maquet)、Medtronic、Tianjin Medical、Braile Biomedica
・地域別グローバル市場分析 2015年-2020年
・人工心肺装置の北米市場(アメリカ、カナダ、メキシコ)
・人工心肺装置のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・人工心肺装置のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・人工心肺装置の南米市場(ブラジル、アルゼンチン)
・人工心肺装置の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:シングルローラーポンプHLM、ダブルローラーポンプHLM
・用途別分析:心臓外科、肺移植手術、急性呼吸不全治療、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The Artificial Cardiopulmonary Machine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Artificial Cardiopulmonary Machine sales will be xx in 2020 from Artificial Cardiopulmonary Machine million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Artificial Cardiopulmonary Machine market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Artificial Cardiopulmonary Machine industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Artificial Cardiopulmonary Machine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Artificial Cardiopulmonary Machine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Artificial Cardiopulmonary Machine market has been segmented into
Single Roller Pump HLM
Double Roller Pump HLM

By Application, Artificial Cardiopulmonary Machine has been segmented into:
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Artificial Cardiopulmonary Machine market presented in the report. This section sheds light on the sales growth of different regional and country-level Artificial Cardiopulmonary Machine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Artificial Cardiopulmonary Machine market.

The report offers in-depth assessment of the growth and other aspects of the Artificial Cardiopulmonary Machine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Artificial Cardiopulmonary Machine Market Share Analysis
Artificial Cardiopulmonary Machine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Artificial Cardiopulmonary Machine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Artificial Cardiopulmonary Machine sales, revenue and market share for each player covered in this report.

The major players covered in Artificial Cardiopulmonary Machine are:
LivaNova (Sorin)
Terumo CV Group
Getinge (Maquet)
Medtronic
Tianjin Medical
Braile Biomedica

Among other players domestic and global, Artificial Cardiopulmonary Machine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Artificial Cardiopulmonary Machine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Artificial Cardiopulmonary Machine, with price, sales, revenue and global market share of Artificial Cardiopulmonary Machine in 2018 and 2019.
Chapter 3, the Artificial Cardiopulmonary Machine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artificial Cardiopulmonary Machine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Artificial Cardiopulmonary Machine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Artificial Cardiopulmonary Machine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Artificial Cardiopulmonary Machine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Artificial Cardiopulmonary Machine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Single Roller Pump HLM
1.2.3 Double Roller Pump HLM
1.3 Market Analysis by Application
1.3.1 Overview: Global Artificial Cardiopulmonary Machine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cardiac Surgery
1.3.3 Lung Transplant Operation
1.3.4 Acute Respiratory Failure Treatment
1.3.5 Others
1.4 Overview of Global Artificial Cardiopulmonary Machine Market
1.4.1 Global Artificial Cardiopulmonary Machine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Artificial Cardiopulmonary Machine Industry Impact
1.6.1 COVID-19 Potential Implications for the Artificial Cardiopulmonary Machine
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Artificial Cardiopulmonary Machine
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 LivaNova (Sorin)
2.1.1 LivaNova (Sorin) Details
2.1.2 LivaNova (Sorin) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 LivaNova (Sorin) SWOT Analysis
2.1.4 LivaNova (Sorin) Product and Services
2.1.5 LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Terumo CV Group
2.2.1 Terumo CV Group Details
2.2.2 Terumo CV Group Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Terumo CV Group SWOT Analysis
2.2.4 Terumo CV Group Product and Services
2.2.5 Terumo CV Group Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Getinge (Maquet)
2.3.1 Getinge (Maquet) Details
2.3.2 Getinge (Maquet) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Getinge (Maquet) SWOT Analysis
2.3.4 Getinge (Maquet) Product and Services
2.3.5 Getinge (Maquet) Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Medtronic
2.4.1 Medtronic Details
2.4.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Medtronic SWOT Analysis
2.4.4 Medtronic Product and Services
2.4.5 Medtronic Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Tianjin Medical
2.5.1 Tianjin Medical Details
2.5.2 Tianjin Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Tianjin Medical SWOT Analysis
2.5.4 Tianjin Medical Product and Services
2.5.5 Tianjin Medical Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Braile Biomedica
2.6.1 Braile Biomedica Details
2.6.2 Braile Biomedica Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Braile Biomedica Product and Services
2.6.4 Braile Biomedica Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Artificial Cardiopulmonary Machine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Artificial Cardiopulmonary Machine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Artificial Cardiopulmonary Machine Manufacturer Market Share in 2019
3.3.2 Top 6 Artificial Cardiopulmonary Machine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Artificial Cardiopulmonary Machine Sales, Revenue and Market Share by Regions
4.1.1 Global Artificial Cardiopulmonary Machine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Artificial Cardiopulmonary Machine Revenue and Market Share by Regions (2015-2020)
4.2 North America Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
4.3 Europe Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
4.5 South America Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Artificial Cardiopulmonary Machine Sales, Revenue and Market Share by Country
5.1.1 North America Artificial Cardiopulmonary Machine Sales and Market Share by Country (2015-2020)
5.1.2 North America Artificial Cardiopulmonary Machine Revenue and Market Share by Country (2015-2020)
5.2 United States Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
5.3 Canada Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
5.4 Mexico Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Artificial Cardiopulmonary Machine Sales, Revenue and Market Share by Country
6.1.1 Europe Artificial Cardiopulmonary Machine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Artificial Cardiopulmonary Machine Revenue and Market Share by Country (2015-2020)
6.2 Germany Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
6.3 UK Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
6.4 France Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
6.5 Russia Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
6.6 Italy Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Artificial Cardiopulmonary Machine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Artificial Cardiopulmonary Machine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Artificial Cardiopulmonary Machine Revenue and Market Share by Regions (2015-2020)
7.2 China Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
7.3 Japan Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
7.4 Korea Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
7.5 India Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
7.7 Australia Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Artificial Cardiopulmonary Machine Sales, Revenue and Market Share by Country
8.1.1 South America Artificial Cardiopulmonary Machine Sales and Market Share by Country (2015-2020)
8.1.2 South America Artificial Cardiopulmonary Machine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
8.3 Argentina Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Artificial Cardiopulmonary Machine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Artificial Cardiopulmonary Machine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Artificial Cardiopulmonary Machine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
9.3 Turkey Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
9.4 Egypt Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
9.5 South Africa Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Artificial Cardiopulmonary Machine Sales and Market Share by Type (2015-2020)
10.2 Global Artificial Cardiopulmonary Machine Revenue and Market Share by Type (2015-2020)
10.3 Global Artificial Cardiopulmonary Machine Price by Type (2015-2020)
11 Global Artificial Cardiopulmonary Machine Market Segment by Application
11.1 Global Artificial Cardiopulmonary Machine Sales Market Share by Application (2015-2020)
11.2 Global Artificial Cardiopulmonary Machine Revenue Market Share by Application (2015-2020)
11.3 Global Artificial Cardiopulmonary Machine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Artificial Cardiopulmonary Machine Sales, Revenue and Growth Rate (2021-2025)
12.2 Artificial Cardiopulmonary Machine Market Forecast by Regions (2021-2025)
12.2.1 North America Artificial Cardiopulmonary Machine Market Forecast (2021-2025)
12.2.2 Europe Artificial Cardiopulmonary Machine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Artificial Cardiopulmonary Machine Market Forecast (2021-2025)
12.2.4 South America Artificial Cardiopulmonary Machine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Artificial Cardiopulmonary Machine Market Forecast (2021-2025)
12.3 Artificial Cardiopulmonary Machine Market Forecast by Type (2021-2025)
12.3.1 Global Artificial Cardiopulmonary Machine Sales Forecast by Type (2021-2025)
12.3.2 Global Artificial Cardiopulmonary Machine Market Share Forecast by Type (2021-2025)
12.4 Artificial Cardiopulmonary Machine Market Forecast by Application (2021-2025)
12.4.1 Global Artificial Cardiopulmonary Machine Sales Forecast by Application (2021-2025)
12.4.2 Global Artificial Cardiopulmonary Machine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Artificial Cardiopulmonary Machine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Artificial Cardiopulmonary Machine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Artificial Cardiopulmonary Machine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Artificial Cardiopulmonary Machine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. LivaNova (Sorin) Basic Information, Manufacturing Base and Competitors
Table 9. LivaNova (Sorin) Artificial Cardiopulmonary Machine Major Business
Table 10. LivaNova (Sorin) Artificial Cardiopulmonary Machine Total Revenue (USD Million) (2018-2019)
Table 11. LivaNova (Sorin) SWOT Analysis
Table 12. LivaNova (Sorin) Artificial Cardiopulmonary Machine Product and Services
Table 13. LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Terumo CV Group Basic Information, Manufacturing Base and Competitors
Table 15. Terumo CV Group Artificial Cardiopulmonary Machine Major Business
Table 16. Terumo CV Group Artificial Cardiopulmonary Machine Total Revenue (USD Million) (2018-2019)
Table 17. Terumo CV Group SWOT Analysis
Table 18. Terumo CV Group Artificial Cardiopulmonary Machine Product and Services
Table 19. Terumo CV Group Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Getinge (Maquet) Basic Information, Manufacturing Base and Competitors
Table 21. Getinge (Maquet) Artificial Cardiopulmonary Machine Major Business
Table 22. Getinge (Maquet) Artificial Cardiopulmonary Machine Total Revenue (USD Million) (2018-2019)
Table 23. Getinge (Maquet) SWOT Analysis
Table 24. Getinge (Maquet) Artificial Cardiopulmonary Machine Product and Services
Table 25. Getinge (Maquet) Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Medtronic Basic Information, Manufacturing Base and Competitors
Table 27. Medtronic Artificial Cardiopulmonary Machine Major Business
Table 28. Medtronic Artificial Cardiopulmonary Machine Total Revenue (USD Million) (2018-2019)
Table 29. Medtronic SWOT Analysis
Table 30. Medtronic Artificial Cardiopulmonary Machine Product and Services
Table 31. Medtronic Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Tianjin Medical Basic Information, Manufacturing Base and Competitors
Table 33. Tianjin Medical Artificial Cardiopulmonary Machine Major Business
Table 34. Tianjin Medical Artificial Cardiopulmonary Machine Total Revenue (USD Million) (2018-2019)
Table 35. Tianjin Medical SWOT Analysis
Table 36. Tianjin Medical Artificial Cardiopulmonary Machine Product and Services
Table 37. Tianjin Medical Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Braile Biomedica Basic Information, Manufacturing Base and Competitors
Table 39. Braile Biomedica Artificial Cardiopulmonary Machine Major Business
Table 40. Braile Biomedica Artificial Cardiopulmonary Machine Total Revenue (USD Million) (2018-2019)
Table 41. Braile Biomedica SWOT Analysis
Table 42. Braile Biomedica Artificial Cardiopulmonary Machine Product and Services
Table 43. Braile Biomedica Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Global Artificial Cardiopulmonary Machine Sales by Manufacturer (2018-2019) (K Units)
Table 45. Global Artificial Cardiopulmonary Machine Revenue by Manufacturer (2018-2019) (USD Million)
Table 46. Global Artificial Cardiopulmonary Machine Sales by Regions (2015-2020) (K Units)
Table 47. Global Artificial Cardiopulmonary Machine Sales Market Share by Regions (2015-2020)
Table 48. Global Artificial Cardiopulmonary Machine Revenue by Regions (2015-2020) (USD Million)
Table 49. North America Artificial Cardiopulmonary Machine Sales by Countries (2015-2020) (K Units)
Table 50. North America Artificial Cardiopulmonary Machine Sales Market Share by Countries (2015-2020)
Table 51. North America Artificial Cardiopulmonary Machine Revenue by Countries (2015-2020) (USD Million)
Table 52. North America Artificial Cardiopulmonary Machine Revenue Market Share by Countries (2015-2020)
Table 53. Europe Artificial Cardiopulmonary Machine Sales by Countries (2015-2020) (K Units)
Table 54. Europe Artificial Cardiopulmonary Machine Sales Market Share by Countries (2015-2020)
Table 55. Europe Artificial Cardiopulmonary Machine Revenue by Countries (2015-2020) (USD Million)
Table 56. Asia-Pacific Artificial Cardiopulmonary Machine Sales by Regions (2015-2020) (K Units)
Table 57. Asia-Pacific Artificial Cardiopulmonary Machine Sales Market Share by Regions (2015-2020)
Table 58. Asia-Pacific Artificial Cardiopulmonary Machine Revenue by Regions (2015-2020) (USD Million)
Table 59. South America Artificial Cardiopulmonary Machine Sales by Countries (2015-2020) (K Units)
Table 60. South America Artificial Cardiopulmonary Machine Sales Market Share by Countries (2015-2020)
Table 61. South America Artificial Cardiopulmonary Machine Revenue by Countries (2015-2020) (USD Million)
Table 62. South America Artificial Cardiopulmonary Machine Revenue Market Share by Countries (2015-2020)
Table 63. Middle East & Africa Artificial Cardiopulmonary Machine Sales by Countries (2015-2020) (K Units)
Table 64. Middle East & Africa Artificial Cardiopulmonary Machine Sales Market Share by Countries (2015-2020)
Table 65. Middle East & Africa Artificial Cardiopulmonary Machine Revenue by Countries (2015-2020) (USD Million)
Table 66. Middle East & Africa Artificial Cardiopulmonary Machine Revenue Market Share by Countries (2015-2020)
Table 67. Global Artificial Cardiopulmonary Machine Sales by Type (2015-2020) (K Units)
Table 68. Global Artificial Cardiopulmonary Machine Sales Share by Type (2015-2020)
Table 69. Global Artificial Cardiopulmonary Machine Revenue by Type (2015-2020) (USD Million)
Table 70. Global Artificial Cardiopulmonary Machine Revenue Share by Type (2015-2020)
Table 71. Global Artificial Cardiopulmonary Machine Sales by Application (2015-2020) (K Units)
Table 72. Global Artificial Cardiopulmonary Machine Sales Share by Application (2015-2020)
Table 73. Global Artificial Cardiopulmonary Machine Sales Forecast by Regions (2021-2025) (K Units)
Table 74. Global Artificial Cardiopulmonary Machine Market Share Forecast by Regions (2021-2025)
Table 75. Global Artificial Cardiopulmonary Machine Sales Forecast by Type (2021-2025) (K Units)
Table 76. Global Artificial Cardiopulmonary Machine Market Share Forecast by Type (2021-2025)
Table 77. Global Artificial Cardiopulmonary Machine Sales Forecast by Application (2021-2025)
Table 78. Global Artificial Cardiopulmonary Machine Market Share Forecast by Application (2021-2025)
Table 79. Direct Channel Pros & Cons
Table 80. Indirect Channel Pros & Cons
Table 81. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Artificial Cardiopulmonary Machine Picture
Figure 2. Global Sales Market Share of Artificial Cardiopulmonary Machine by Type in 2019
Figure 3. Single Roller Pump HLM Picture
Figure 4. Double Roller Pump HLM Picture
Figure 5. Artificial Cardiopulmonary Machine Sales Market Share by Application in 2018
Figure 6. Cardiac Surgery Picture
Figure 7. Lung Transplant Operation Picture
Figure 8. Acute Respiratory Failure Treatment Picture
Figure 9. Others Picture
Figure 10. Global Artificial Cardiopulmonary Machine Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Artificial Cardiopulmonary Machine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Artificial Cardiopulmonary Machine Sales Market Share by Manufacturer in 2019
Figure 31. Global Artificial Cardiopulmonary Machine Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Artificial Cardiopulmonary Machine Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Artificial Cardiopulmonary Machine Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Artificial Cardiopulmonary Machine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Artificial Cardiopulmonary Machine Revenue Market Share by Regions (2015-2020)
Figure 38. Global Artificial Cardiopulmonary Machine Revenue Market Share by Regions in 2018
Figure 39. North America Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
Figure 40. Europe Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
Figure 42. South America Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020)
Figure 44. North America Artificial Cardiopulmonary Machine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Artificial Cardiopulmonary Machine Sales Market Share by Countries (2015-2020)
Figure 46. North America Artificial Cardiopulmonary Machine Sales Market Share by Countries in 2018
Figure 47. North America Artificial Cardiopulmonary Machine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Artificial Cardiopulmonary Machine Revenue Market Share by Countries in 2018
Figure 49. United States Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Artificial Cardiopulmonary Machine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Artificial Cardiopulmonary Machine Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Artificial Cardiopulmonary Machine Revenue Market Share by Countries in 2019
Figure 55. Germany Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Artificial Cardiopulmonary Machine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Artificial Cardiopulmonary Machine Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Artificial Cardiopulmonary Machine Revenue Market Share by Regions 2019
Figure 63. China Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Artificial Cardiopulmonary Machine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Artificial Cardiopulmonary Machine Sales Market Share by Countries in 2019
Figure 70. South America Artificial Cardiopulmonary Machine Revenue Market Share by Countries in 2019
Figure 71. Brazil Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Artificial Cardiopulmonary Machine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Artificial Cardiopulmonary Machine Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Artificial Cardiopulmonary Machine Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Artificial Cardiopulmonary Machine Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Artificial Cardiopulmonary Machine Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Artificial Cardiopulmonary Machine Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Artificial Cardiopulmonary Machine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Artificial Cardiopulmonary Machine Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Artificial Cardiopulmonary Machine Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Artificial Cardiopulmonary Machine Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Artificial Cardiopulmonary Machine Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Artificial Cardiopulmonary Machine Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel